))
Aspira Women’s Health CEO Nicole Sandford on OvaWatch Progress and Recent Financing
Manage episode 429334557 series 3486351
Contenido proporcionado por Water Tower Research. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Water Tower Research o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Aspira CEO and Director Nicole Sandford joins the Water Tower Hour Podcast to discuss recent updates on OvaSuite, including preliminary 2Q24 OvaWatch volume growth and the launch of mass monitoring. She walks us through what is driving OvaWatch growth and the messaging to physicians and patients around the value of proper malignancy risk assessment prior to surgical intervention. In addition, she reviews the recent private placement financing and potential opportunities for the company’s biobank of patient samples, including academic collaborations.
99 episodios
Compartir
